These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2120745)

  • 1. Evaluation of thyrotropin releasing hormone as a therapeutic intervention for endotoxemia.
    Brackett DJ; Schaefer CF; Lerner MR; Holaday JW; Fagraeus L; Wilson MF
    Regul Pept; 1990 Jul; 29(2-3):153-62. PubMed ID: 2120745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiorespiratory alterations produced by centrally administered thyrotropin-releasing hormone during canine endotoxin shock.
    Leffew SD; Williams CD; Janssen HF
    Circ Shock; 1987; 21(3):225-32. PubMed ID: 3105908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl sulfoxide antagonizes hypotensive, metabolic, and pathologic responses induced by endotoxin.
    Brackett DJ; Lerner MR; Wilson MF
    Circ Shock; 1991 Mar; 33(3):156-63. PubMed ID: 2044208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin releasing hormone improves blood pressure and survival in endotoxic shock.
    Holaday JW; Ruvio BA; Faden AI
    Eur J Pharmacol; 1981 Aug; 74(1):101-5. PubMed ID: 6797829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shock.
    Holaday JW; Faden AI
    Regul Pept; 1983 Oct; 7(2):111-25. PubMed ID: 6419292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock.
    Gurll NJ; Holaday JW; Reynolds DG; Ganes E
    Crit Care Med; 1987 Jun; 15(6):574-81. PubMed ID: 3105962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefits of corticosteroid given after the onset of hypotension during endotoxin shock in the conscious rat.
    Schaefer CF; Brackett DJ; Wilson MF
    Adv Shock Res; 1983; 10():183-94. PubMed ID: 6349297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory and cardiovascular effects of thyrotropin-releasing hormone as modified by isoflurane, enflurane, pentobarbital and ketamine.
    Schaefer CF; Brackett DJ; Biber B; Lerner MR; Holaday JW; Wilson MF; Fagraeus L
    Regul Pept; 1989 Mar; 24(3):269-82. PubMed ID: 2496439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of plasma histamine concentrations during documented endotoxic shock.
    Brackett DJ; Hamburger SA; Lerner MR; Jones SB; Schaefer CF; Henry DP; Wilson MF
    Agents Actions; 1990 Nov; 31(3-4):263-74. PubMed ID: 2085142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of central choline during endotoxin shock in the rat.
    Savci V; Ulus IH
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):667-75. PubMed ID: 9388050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
    Qi M; Jones SB
    Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of naloxone and thyrotropin-releasing hormone on plasma catecholamines, corticosterone, and arterial pressure in normal and endotoxemic rats.
    Long JB; Lake CR; Reid AA; Holaday JW
    Circ Shock; 1986; 18(1):1-10. PubMed ID: 3080257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of H1 and H2 histamine receptor antagonists on the development of endotoxemia in the conscious, unrestrained rat.
    Brackett DJ; Schaefer CF; Wilson MF
    Circ Shock; 1985; 16(2):141-53. PubMed ID: 2414028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and respiratory effects of thyrotropin-releasing hormone and epinephrine in anaphylactic shock.
    Muelleman RL; Gatz M; Salomone JA; Herndon B; Salzman GA
    Ann Emerg Med; 1989 May; 18(5):534-41. PubMed ID: 2497665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone increases survival in canine hemorrhagic shock.
    Sugiura A; Smith RA; Shatney CH
    J Surg Res; 1986 Jan; 40(1):63-8. PubMed ID: 3079847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin-induced hypotension in rats is not mediated by prekallikrein activation.
    Kaufmann U; Schapira M; Waeber B; Nussberger J; Brunner HR
    Circ Shock; 1987; 23(3):215-23. PubMed ID: 2448054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
    Cunha-Goncalves D; Perez-de-Sa V; Grins E; Dahm PL; Thörne J; Blomquist S
    Anesth Analg; 2009 Nov; 109(5):1568-75. PubMed ID: 19713249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.
    Cunha-Goncalves D; Perez-de-Sa V; Larsson A; Thörne J; Blomquist S
    Anesth Analg; 2009 Nov; 109(5):1576-83. PubMed ID: 19713252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat.
    Sirén AL; Powell E; Feuerstein G
    Am J Physiol; 1986 Jun; 250(6 Pt 2):H1093-101. PubMed ID: 3087219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and metabolic effects of vasopressin blockade in endotoxin shock.
    Matsuoka T; Wisner DH
    Surgery; 1997 Feb; 121(2):162-73. PubMed ID: 9037228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.